AIDS experts go back to basics

March 27, 2008

The head of the U.S. agency in charge of AIDS research says scientists need to go back to basics to find a vaccine against the HIV virus.

Dr. Anthony S. Fauci of the National Institute of Allergy and Infectious Diseases said the agency will re-evaluate the use of the $1.5 billion it spends on AIDS research, The New York Times reported Wednesday. He said more basic laboratory research is needed to understand the way the body and experimental vaccines respond to HIV.

"There is not an immediate solution to the problem," Fauci told the newspaper at a summit Tuesday in Bethesda, Md., to discuss fallout from last year's failure of the most promising candidate for an HIV vaccine.

Fauci rejected the AIDS Health Care Foundation's call for the suspension of money for HIV vaccine research in favor of increased AIDS prevention efforts. "Under no circumstances will we stop AIDS vaccine research," he said.

Copyright 2008 by United Press International

Explore further: Fresh approach to tuberculosis vaccine offers better protection

Related Stories

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

More than one third of U.S. HIV patients fail to receive vaccination for hepatitis B

December 25, 2017
Despite their high risk for infection, more than one third of U.S. HIV patients fail to get vaccinated for hepatitis B. The findings are published in Annals of Internal Medicine.

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.

Could gene therapy someday eliminate HIV?

January 3, 2018
(HealthDay)—Gene therapy may have the potential to eradicate HIV in people infected with the virus, new animal research suggests.

Epidemic of opioid abuse is top health story of 2017

December 28, 2017
(HealthDay)—The millions of Americans caught in the grip of an addiction to opioids—prescription painkillers or heroin—remained the leading health news story of the past year.

Four big insights into HIV/AIDS that provide hope of finding a vaccine

November 24, 2017
HIV remains one of the continent's most intractable health challenges. Tremendous progress is being made to understand the virus, the immune mechanisms that contribute to its control and for new antiretroviral drugs and vaccines ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

sheber
4 / 5 (1) Mar 27, 2008
How far are they planning to go back? http://www.uow.ed...ts/AIDS/
Sepp
not rated yet Mar 28, 2008
Sheber,

just my question. How far are they willing to go back. Is HIV as an agent of causation also part of the question?

http://www.newmed...rror.htm

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.